Chicken Pox

Presumptive Vaccination Cost Effective Until Age 12

Published in Vaccine Weekly, July 3rd, 1995

Presumptive vaccination of children up to 12 years of age with a negative or uncertain history of varicella appears to be cost effective, but such vaccination is not cost-effective for older children, according to a report from the healthcare provider KaiserPermanente.

Varicella virus causes more than 3.7 million cases of chicken pox in the United States each year. A safe and effective vaccine has been approved by the U.S. Food and Drug Administration and is likely to be recommended for universal use in toddlers. However, for older children and adolescents with a negative or uncertain history of chicken pox, the decision about whether to vaccinate presumptively is...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1995-07-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry